Who
Mike Mensinger
Chief Product Officer
Company insider
Files Form 4 as: Chief Product Officer, Beta Bionics.
In numbers
- Trades disclosed
- 37
- Buys
- 1
- Sells
- 10
- Bought
- $567K
- Sold
- $1.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Jan 2025
- Last trade
- 16 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Jan 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Sep 2026filed 17 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $58K2,650 at $22.00 | filing |
| 16 Sep 2026filed 17 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $58K2,650 at $22.00 | filing |
| 2 Sep 2026filed 3 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $84K4,375 at $19.11 | filing |
| 2 Sep 2026filed 3 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $84K4,375 at $19.11 | filing |
| 2 Jun 2026filed 3 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $55K4,378 at $12.61 | filing |
| 2 Jun 2026filed 3 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $55K4,378 at $12.61 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $13K1,064 at $12.36 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $13K1,064 at $12.36 | filing |
| 27 Feb 2026filed 13 Mar 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —91,520 at $0.00 | filing |
| 27 Feb 2026filed 13 Mar 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —91,520 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code A | —109,105 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —58,749 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —58,749 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code A | —109,105 at $0.00 | filing |
| 6 Jan 2026filed 7 Jan 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $66K2,200 at $30.10 | filing |
| 6 Jan 2026filed 7 Jan 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $66K2,200 at $30.10 | filing |
| 2 Jan 2026filed 5 Jan 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $213K7,200 at $29.56 | filing |
| 2 Jan 2026filed 5 Jan 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $18K600 at $30.20 | filing |
| 2 Jan 2026filed 5 Jan 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $213K7,200 at $29.56 | filing |
| 2 Jan 2026filed 5 Jan 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $18K600 at $30.20 | filing |
News
Investor Notification: Beta Bionics ($BBNX) Investors Are Reminded to Contact BFA Law About the Ongoing Securities Fraud Class Action to Recover LossesBBNX · thesudburystar.com · 24 Oct 2026BBNX DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action - BBNXBBNX · wallstreet-online.de · 22 Oct 2026BETA BIONICS, INC. (NASDAQ: BBNX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by November 3, 2026BBNX · prnewswire.com · 20 Oct 2026
0 headlines in the last 90 days name Mike Mensinger; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.